The pursuit of platelet safety.
作者信息
Ness Paul M
机构信息
Transfusion Medicine Division, Department of Pathology, Johns Hopkins Medical Institutions, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
出版信息
Transfusion. 2022 Jun;62(6):1302-1304. doi: 10.1111/trf.16898. Epub 2022 May 4.
Abstract
摘要
相似文献
1
The pursuit of platelet safety.对血小板安全性的追求。
Transfusion. 2022 Jun;62(6):1302-1304. doi: 10.1111/trf.16898. Epub 2022 May 4.
2
Effects Of Glycoprotein IIb/IIIa Antagonists: Anti Platelet Aggregation And Beyond.糖蛋白IIb/IIIa拮抗剂的作用：抗血小板聚集及其他作用
Curr Drug Metab. 2016;17(2):194-203. doi: 10.2174/1389200217666151211121112.
3
4
Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release.糖蛋白IIb/IIIa抑制作用可增强血小板一氧化氮的释放。
Thromb Res. 2004;113(3-4):225-33. doi: 10.1016/j.thromres.2004.02.018.
5
FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.FcγRII介导由去整合素和GPIIb/IIIa单克隆抗体AP2引起的血小板聚集。
Exp Hematol. 2008 Dec;36(12):1704-13. doi: 10.1016/j.exphem.2008.07.006. Epub 2008 Sep 21.
6
Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.非肽类分子BIBU52对糖蛋白IIb/IIIa受体的拮抗作用：体外抑制血小板聚集及体内抗血栓形成疗效
J Cardiovasc Pharmacol. 1997 Aug;30(2):261-72. doi: 10.1097/00005344-199708000-00017.
7
Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.使用血栓弹力图比较不同血小板糖蛋白IIb/IIIa拮抗剂对组织因子诱导的血小板介导的血凝块强度的体外疗效：糖蛋白IIb/IIIa拮抗剂之间的差异
Arterioscler Thromb Vasc Biol. 2000 Apr;20(4):1162-7. doi: 10.1161/01.atv.20.4.1162.
8
Differential antiplatelet effects of various glycoprotein IIb-IIIa antagonists.各种糖蛋白IIb-IIIa拮抗剂的抗血小板差异效应。
Thromb Res. 2001 Jan 15;101(2):53-64. doi: 10.1016/s0049-3848(00)00385-6.
9
本文引用的文献
1
How platelet transfusions were invented.血小板输血是如何发明的。
Transfusion. 2021 Dec;61(12):3483-3486. doi: 10.1111/trf.16727.
2
Pathogen inactivation of platelets for transfusion.血小板的病原体灭活用于输血。
Platelets. 2022 Jan 2;33(1):23-26. doi: 10.1080/09537104.2021.1935838. Epub 2021 Jun 6.
3
Implementation of secondary bacterial culture testing of platelets to mitigate residual risk of septic transfusion reactions.开展血小板的二次细菌培养检测以降低感染性输血反应的残余风险。
Transfusion. 2018 Jul;58(7):1647-1653. doi: 10.1111/trf.14618. Epub 2018 Apr 1.
4
Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions.血液成分单采技术与血小板的细菌污染以及报告的败血症性输血反应相关。
Transfusion. 2017 Dec;57(12):2969-2976. doi: 10.1111/trf.14308. Epub 2017 Sep 6.
5
Platelet transfusions: are we ready to chill out?血小板输注：我们准备好放松了吗？
Br J Haematol. 2017 Jul;178(1):7-8. doi: 10.1111/bjh.14750. Epub 2017 Jun 14.
6
Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure.英国国民医疗服务体系血液与移植部门对血小板成分进行细菌筛查，这是一项有效的风险降低措施。
Transfusion. 2017 May;57(5):1122-1131. doi: 10.1111/trf.14085.
7
Alternatives to allogeneic platelet transfusion.异体血小板输注的替代方法。
Br J Haematol. 2016 Nov;175(3):381-392. doi: 10.1111/bjh.14338. Epub 2016 Sep 21.
8
Detection of septic transfusion reactions to platelet transfusions by active and passive surveillance.主动和被动监测对血小板输注后脓毒性输血反应的检测。
Blood. 2016 Jan 28;127(4):496-502. doi: 10.1182/blood-2015-07-655944. Epub 2015 Nov 23.
9
Addressing the risk of bacterial contamination of platelets within the United States: a history to help illuminate the future.应对美国国内血小板细菌污染风险：一段照亮未来的历史。
Transfusion. 2013 Jan;53(1):221-31. doi: 10.1111/j.1537-2995.2012.03708.x. Epub 2012 May 21.
10
Detection of bacterial contamination in prestorage culture-negative apheresis platelets on day of issue with the Pan Genera Detection test.使用 Pan 通用检测试验在发出日检测储存前培养阴性的单采血小板中的细菌污染。
Transfusion. 2011 Dec;51(12):2573-82. doi: 10.1111/j.1537-2995.2011.03308.x. Epub 2011 Aug 29.
Zotero 插件